Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Immunology Research
Cancer Immunology Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Cancer Immunology Essentials
    • Collections
      • COVID-19 & Cancer Resource Center
      • "Best of" Collection
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

More articles from Other Topics: Poster Presentations - Proffered Abstracts

  • Abstract B86: Radiation and TGFβ blockade bring back memories in metastatic breast cancer patients
    Dörthe Schaue, Michael W. Xie, Josephine A. Ratikan, Ewa D. Micewicz, Lin Hwang, Kym F. Faull, James W. Sayre, Percy P. Lee, John A. Glaspy, Sandra Demaria, Silvia C. Formenti, William H. McBride
    Cancer Immunology Research Mar 2017, 5 (3 Supplement) B86; DOI: 10.1158/2326-6074.TUMIMM16-B86
  • Abstract B88: TGF-β pathway-mediated escape from VEGF blockade is linked with angiogenesis and immune-suppression in murine glioma models
    Davide Mangani, Michael Weller, Emad Seyed Sadr, Edith Willscher, Katharina Seystahl, Guido Reifenberger, Ghazaleh Tabatabai, Hans Binder, Hannah Schneider
    Cancer Immunology Research Mar 2017, 5 (3 Supplement) B88; DOI: 10.1158/2326-6074.TUMIMM16-B88
  • Abstract B70: Canine Parvovirus-based immunotherapy in breast cancer patients, as coadjuvant treatment to surgery management: 9 years survival following
    Hugo Ramiro Segura-Puello, Juan Sebastian Segura-Charry, Ingrid Tatiana Gomez-Martinez, Sandra Viviana Guitarrero-Bustos, Diana Lorena Nieto-Mosquera
    Cancer Immunology Research Mar 2017, 5 (3 Supplement) B70; DOI: 10.1158/2326-6074.TUMIMM16-B70
  • Abstract B65: Alteration in cholesterol homeostasis and antibody synthesis in B cells an in-vivo effect of carcinogen (polyaromatic)
    Nimisha Saxena, Amar Preet Kaur, Nimai Chand Chandra
    Cancer Immunology Research Mar 2017, 5 (3 Supplement) B65; DOI: 10.1158/2326-6074.TUMIMM16-B65
  • Abstract B67: Antibody-mediated delivery of viral peptides selectively activates CD8+ T cells to eliminate tumor cells in vitro and in vivo
    Julian Peter Sefrin, Lars Hillringhaus, Valeria Lifke, Alexander Lifke
    Cancer Immunology Research Mar 2017, 5 (3 Supplement) B67; DOI: 10.1158/2326-6074.TUMIMM16-B67
  • Abstract B84: Preclinical analysis of combinatorial glioblastoma therapy with the prodrug-mediated gene therapy vector AdV-TK and immune checkpoint inhibition
    Maria Carmela Speranza, Franz Ricklefs, Carmela Passaro, Sarah R. Klein, Kazue Kasai, Johanna Kaufmann, Hiroshi Nakashima, Bronisz Agnieszka, Estuardo Aguilar-Cordova, Brian W. Guzik, Gordon J. Freeman, David A. Reardon, Patrick Wen, E. Antonio Chiocca, Sean E. Lawler
    Cancer Immunology Research Mar 2017, 5 (3 Supplement) B84; DOI: 10.1158/2326-6074.TUMIMM16-B84
  • Abstract B89: The chimeric antibody NZ-12 or CAR T cells targeting human podoplanin possesses antitumor activity against orthotopic xenograft models
    Yukinari Kato, Satoshi Shiina, Atsushi Natsume, Shinji Abe, Yasuhiko Nishioka, Satoshi Ogasawara, Mika K. Kaneko
    Cancer Immunology Research Mar 2017, 5 (3 Supplement) B89; DOI: 10.1158/2326-6074.TUMIMM16-B89
  • Abstract B72: Combining immune checkpoint inhibition and DNA damage repair (DDR) targeted therapy in small cell lung cancer (SCLC)
    Triparna Sen, Limo Chen, Bertha Leticia Rodriguez, Yongbin Yang, You Hong Fan, Catherine Allison Stewart, Bonnie Glisson, Helen Piwnica-Worms, Julien Sage, John V. Heymach, Don L. Gibbons, Lauren A. Byers
    Cancer Immunology Research Mar 2017, 5 (3 Supplement) B72; DOI: 10.1158/2326-6074.TUMIMM16-B72
  • Abstract B73: Computational model of combined cancer treatment with radiotherapy and anti-PD-1 immunotherapy
    Damijan Valentinuzzi, Katja Ursic, Martina Vrankar, Urban Simoncic, Urban Simoncic, Robert Jeraj
    Cancer Immunology Research Mar 2017, 5 (3 Supplement) B73; DOI: 10.1158/2326-6074.TUMIMM16-B73
  • Abstract B80: Natural killer and dendritic cells collaborate in the immune response induced by Cetuximab and IL-15 against triple negative breast cancer
    Estefanía P. Juliá, María Betina Pampena, Yamila S. Rocca, José Mordoh, Estrella M. Levy
    Cancer Immunology Research Mar 2017, 5 (3 Supplement) B80; DOI: 10.1158/2326-6074.TUMIMM16-B80

Pages

  • Previous
  • Next
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 17
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Cancer Immunology Essentials

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Immunology Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Immunology Research
eISSN: 2326-6074
ISSN: 2326-6066

Advertisement